No Detail Found!

Salvia miltiorrhiza adjuvant therapy facilitates cardiac function recovery in patients with myocardial infarction

Author(s)
Mei Zhang Department of Emergency, Shanghai Changhai Hospital, Naval Medical University,Shanghai,China
Ying Liu Department of Emergency, Shanghai Changhai Hospital, Naval Medical University,Shanghai,China
Xingcheng Sun Department of Emergency, Shanghai Changhai Hospital, Naval Medical University,Shanghai,China
Xiaoqing Zhang Department of Emergency, Shanghai Changhai Hospital, Naval Medical University,Shanghai,China
Libo Hua Department of Emergency, Shanghai Changhai Hospital, Naval Medical University,Shanghai,China
Abstract
Myocardial infarction (MI), a leading cause of global mortality, often leads to heart failure and impaired quality of life. This randomized controlled trial evaluated Salvia miltiorrhiza (SM), a traditional Chinese herb containing bioactive compounds like tanshinone IIA and salvianolic acid A, as an adjunct therapy for acute MI. SM is known for anti-inflammatory, antioxidant, anticoagulant and microcirculatory benefits. In the study, 120 MI patients were divided into two groups: routine treatment (RT) and RT plus SM injection. After two weeks, the SM group demonstrated significantly increased left ventricular ejection fraction (LVEF) and reduced left ventricular end-systolic and enddiastolic diameters (LVESD, LVEDD) compared to RT (P<0.001). Hemodynamic parameters-cardiac output (CO), cardiac index (CI), and stroke volume (SV) also improved markedly in the SM group. Additionally, SM enhanced vascular endothelial function and lowered serum markers of myocardial injury. These findings suggest SM supplementation synergizes with conventional therapies to accelerate cardiac functional recovery and hemodynamic stabilization in MI patients. The study highlights SM's potential as a safe, effective adjuvant treatment for MI, warranting further clinical exploration.
Publication Details
Page(s) 45-53
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 1, Year: 2025

Request the full text from PASTIC

Keywords
Myocardial Infarction, Cardiac Function, Vascular endothelial function, Chinese medicine adjuvant therapy, Salvia miltiorrhiza
References
Akhtar K,Khan M,Baron S,Zieroth S,Estep J,Burkhoff D,Butler J,Fudim M .2024 .The spectrum of postmyocardial infarction care: From acute ischemia to heart failure. Prog. Cardiovasc. Dis., 82 : 15-25.
Brewster L,Garcia V,Levy M,Stockelman K,Goulding A,DeSouza N,Greiner J,Hijmans J,DeSouza C J .1985 .Endothelin-1-induced endothelial microvesicles impair endothelial cell function. J. Appl Physiol, 128(6) : 1497-1505.
Chai R,Ye Z,Xue W,Shi S,Wei Y,Hu Y,Wu H Y .2023 .Tanshinone IIA inhibits cardiomyocyte pyroptosis through TLR4/NF-κB p65 pathway after acute myocardial infarction. Front. Cell Dev, 11 : 1252942.
Cyr A,Huckaby L,Shiva S,Zuckerbraun B .2020 .Nitric oxide and endothelial dysfunction. Crit. Care Clin., 36(2) : 307-321.
Ding B,Lin C,Liu Q,He Y,Ruganzu J,Jin H,Peng X,Ji S,Ma Y,Yang W .2020 .Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-κB signaling pathway in vivo and in vitro. J Neuroinflammation, 17(1) : 302.
Dyrbus K,Gąsior M,Desperak P,Osadnik T,Nowak J,Banach M .2019 .The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in the Polish tertiary centre: Results from the TERCET registry with 19,781 individuals. , 288 : 33-41.
Fang Y,Duan C,Chen S,Liu Z,Jiang B,Ai W,Wang L,Xie P,Fang H P .2021 .Tanshinone-IIA inhibits myocardial infarct via decreasing of the mitochondrial apoptotic signaling pathway in myocardiocytes. Int. J. Mol Med, 48(2) : 158.
Gilliland T,Liu Y,Mohebi R,Miksenas H,Haidermota S,Wong M,Hu X,Cristino J,Browne A,Plutzky J .2023 .Lipoprotein(a), oxidized phospholipids, and coronary artery disease severity and outcomes. J. Am. Coll. Cardiol., 81(18) : 1780-1792.
Mehta S Grines C .2021 .ST-segment elevation myocardial infarction management: Great strides but still room for improvement. Eur. Heart J., 42(44) : 4550-4552.
Guo R,Li L,Su J,Li S,Duncan SE,Liu Z,Fan G .2020 .Pharmacological activity and mechanism of tanshinone IIA in related diseases. Drug Des. Devel. Ther., 14 : 4735-4748.
Hempel T,Wyatt A .2022 .High sensitivity troponins. Emerg. Med, 40(4) : 809-821.
Hu J,Zhao M,Hou Z,Shang J .2020 .The complete chloroplast genome sequence of Salvia miltiorrhiza, a medicinal plant for preventing and treating vascular dementia. Mitochondrial DNA B Resour, 5(3) : 2460-2462.
Huang J,Zhang J,Sun C,Yang R,Sheng M,Hu J,Kai G,Pt B .2024 .Adjuvant role of Salvia miltiorrhiza bunge in cancer chemotherapy: A review of its bioactive components, health-promotion effect and mechanisms. J. Ethnopharmacol., 117022 : .
Jin H,Peng X,He Y,Ruganzu J,Yang W .2020 .Tanshinone IIA suppresses lipopolysaccharide-induced neuroinflammatory responses through NF-κB/MAPKs signaling pathways in human U87 astrocytoma cells. Brain Res. Bull., 164 : 136-145.
Li B,Lv J,Han S,Chen R,Hu Y,Fang J,Wang Z,Zhong W,Hu Y,Liu W Y .2024 .Successful percutaneous coronary intervention in a congenital single right coronary artery with acute myocardial infarction: A case report and literature review. Medicine (Baltimore), 103(31) : e39143.
Li D,Yang Z,Gao S,Zhang H,Fan G H .2022 .Tanshinone IIA ameliorates myocardial ischemia/reperfusion injury in rats by regulation of NLRP3 inflammasome activation and Th17 cells differentiation. Acta Cir, 37(7) : e370701.
Lian B,Zeng R,Chen Y,Liao P,Guo L,Zhang M .2021 .Sodium Tanshinone IIA sulfonate for acute myocardial infarction: A systematic review and Metaanalysis. J. Tradit. Chin. Med, 41(1) : 26-35.
Lin S,He X,Zhai G,Wang C,Xue H,Lin S H .2021 .Prospective study of the effect of sulfotanshinone sodium combined with tirofiban on vascular endothelial function and indicators of plaque stability in elderly patients with acute coronary syndrome. J. Clin. Pharm, 46(2) : 319-327.
Lu T,Wu Y,Chen W,Hung Y .2022 .Targeting oxidative stress and endothelial dysfunction using Tanshinone IIA for the treatment of tissue inflammation and fibrosis. Oxid. Med, : 2811789.
Pilarczyk K,Werdan K,Russ M,Thiele H,Michels G,Boeken U,Thielmann M U .2021 .The GermanAustrian S3 Guideline, Cardiogenic shock due to myocardial infarction: Diagnosis, monitoring, and treatment. Thorac Cardiovasc Surg., 69(8) : 684-692.
Shamaki G,Markson F,Soji-Ayoade D,Agwuegbo C,Bamgbose M,Tamunoinemi B M .2022 .Peripheral artery disease: A comprehensive updated review. Curr. Probl. Cardiol., 47(11) : 101082.
Yin X,Huang Y,Li Z,Dong J,Zou J,Tian L,Yang J .2022 .Efficacy and safety of intracoronary prourokinase injection during percutaneous coronary intervention in treating ST elevation myocardial infarction patients: a systematic review and metaanalysis of randomized controlled trials. Eur. Rev. Med, 26(16) : 5802-5813.
Yin Z,Wang X,Yang X,Chen Y,Duan Y,Han J .2021 .Salvia miltiorrhiza in anti-diabetic angiopathy. Curr. Mol. Pharmacol, 14(6) : 960-974.
Zifu T,Jiaquan L,Juan Z L .2022 .Effect of Qingre Jiedu Huoxue Huayu recipe on blood stasis and toxin syndrome in patients with non-ST segment elevation acute coronary syndrome, serum Lp-PLA2, TNF- α, and PIGF expression level. Cell. Mol. Biol. (Noisy-legrand), 67(4) : 121-129.
Zuchi C,Tritto I,Carluccio E,Mattei C,Cattadori G,Ambrosio G .2020 .Role of endothelial dysfunction in heart failure. Heart Fail. Rev., 25(1) : 21-30.
0

Citations

0

Downloads

67

Views